Kewaunee Scientific (NASDAQ:KEQU) Downgraded by StockNews.com to “Hold”

StockNews.com downgraded shares of Kewaunee Scientific (NASDAQ:KEQU) from a buy rating to a hold rating in a research note issued to investors on Friday morning.

Kewaunee Scientific Stock Down 1.3 %

KEQU stock opened at $47.58 on Friday. Kewaunee Scientific has a one year low of $30.74 and a one year high of $71.33. The stock has a market capitalization of $136.65 million, a PE ratio of 7.54 and a beta of 0.71. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. The company has a fifty day moving average of $58.59 and a 200-day moving average of $47.82.

Kewaunee Scientific (NASDAQ:KEQU) last released its earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The company had revenue of $67.17 million during the quarter.

Insider Activity at Kewaunee Scientific

In related news, CFO Donald T. Gardner III sold 1,257 shares of the firm’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $59.26, for a total value of $74,489.82. Following the completion of the sale, the chief financial officer now owns 21,358 shares in the company, valued at $1,265,675.08. This trade represents a 5.56 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Elizabeth D. Phillips sold 1,850 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the sale, the vice president now owns 13,591 shares of the company’s stock, valued at $736,224.47. This trade represents a 11.98 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 11,994 shares of company stock worth $729,430 over the last 90 days. Company insiders own 14.20% of the company’s stock.

Institutional Trading of Kewaunee Scientific

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE raised its position in Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after acquiring an additional 443 shares during the last quarter. Jane Street Group LLC acquired a new position in Kewaunee Scientific during the fourth quarter worth about $300,000. Marshall Wace LLP acquired a new position in Kewaunee Scientific during the fourth quarter worth about $736,000. Invesco Ltd. acquired a new position in Kewaunee Scientific during the fourth quarter worth about $6,545,000. Finally, Wedbush Securities Inc. acquired a new position in Kewaunee Scientific during the fourth quarter worth about $262,000. Institutional investors and hedge funds own 32.69% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.